Moderna Stock Gains After Smashing Q1 Earnings Forecast, Affirming Vaccine Sales Forecast

Moderna  (MRNA) - shares surged higher Wednesday after the drugmaker posted much stronger-than-expected first quarter earnings while re-affirming its full-year forecast for Covid vaccine sales.